{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:45:40Z","timestamp":1790790340255,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cardfail.2022.12.012","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T12:54:33Z","timestamp":1673268873000},"page":"517-526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7493-3626","authenticated-orcid":false,"given":"ALEKSANDER","family":"SINIARSKI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5083-7587","authenticated-orcid":false,"given":"ALEKSANDRA","family":"G\u0104SECKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSIP ANDELO","family":"BOROVAC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PANTELEIMON E.","family":"PAPAKONSTANTINOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DARIO","family":"BONGIOVANNI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HANNE","family":"EHRLINDER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHELA","family":"GIUSTOZZI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUI AZEVEDO","family":"GUERREIRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WILLIAM A.E.","family":"PARKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2022.12.012_bib0001","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0003","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.114.011353","article-title":"Thrombotic complications in heart failure: an underappreciated challenge","volume":"130","author":"Shantsila","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0004","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1093\/eurheartj\/ehz427","article-title":"A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial","volume":"40","author":"Mehra","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/eurjhf\/hfs171","article-title":"Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm","volume":"15","author":"Hopper","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0006","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0007","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.103.13.1746","article-title":"Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm","volume":"103","author":"Gibbs","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0008","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1536\/ihj.20-248","article-title":"Anticoagulation in patients with heart failure and sinus rhythm","volume":"61","author":"Li","year":"2020","journal-title":"Int Heart J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12917-020-02692-x","article-title":"Platelet proteome changes in dogs with congestive heart failure","volume":"16","author":"Levent","year":"2020","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2796.2007.01891.x","article-title":"Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity","volume":"263","author":"Chung","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0011","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.thromres.2007.01.003","article-title":"Platelet activation in acute, decompensated congestive heart failure","volume":"120","author":"Chung","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/CIRCHEARTFAILURE.112.968073","article-title":"Increased formation of monocyte-platelet aggregates in ischemic heart failure","volume":"6","author":"Wrigley","year":"2013","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ahj.2004.03.010","article-title":"The Warfarin\/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure","volume":"148","author":"Cleland","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0014","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejheart.2006.02.012","article-title":"HELAS investigators. Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study","volume":"8","author":"Cokkinos","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0015","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0016","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0017","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/hrt.2010.192740","article-title":"Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism","volume":"96","author":"Palka","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0018","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/CIRCULATIONAHA.106.661397","article-title":"Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"115","author":"Freudenberger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0019","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0735-1097(97)00019-3","article-title":"Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials","volume":"29","author":"Dries","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJM199701233360403","article-title":"Ventricular dysfunction and the risk of stroke after myocardial infarction","volume":"336","author":"Loh","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0021","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2008.03.041","article-title":"Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction","volume":"52","author":"Weinsaft","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0022","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/ehf2.13196","article-title":"The prevalence, predictors, and outcomes of spontaneous echocardiographic contrast or left ventricular thrombus in patients with HFrEF","volume":"8","author":"Zhou","year":"2021","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0023","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ehf2.12455","article-title":"Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry\u00ae","volume":"6","author":"Ibrahim","year":"2019","journal-title":"ESC Hear Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0024","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0025","first-page":"1","article-title":"Anticoagulants for stroke prevention in heart failure with reduced ejection fraction","author":"Sch\u00e4fer","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0026","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0027","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.119.039609","article-title":"Rivaroxaban with or without aspirin in patients with heart failure and chronic coronary or peripheral artery disease: the COMPASS trial","volume":"140","author":"Branch","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0028","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jamacardio.2019.1049","article-title":"Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial","volume":"4","author":"Greenberg","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0029","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0030","first-page":"1424","article-title":"Does heart failure confer a hypercoagulable state? Virchow's triad revisited","volume":"33","author":"Lip","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0031","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/174182679500200203","article-title":"Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?","volume":"2","author":"Katz","year":"1995","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0032","first-page":"1082","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"70","author":"Ib\u00e1nez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0033","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0034","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/ehjcvp\/pvaa096","article-title":"The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction","volume":"7","author":"Jones","year":"2021","journal-title":"Eur Hear J-Cardiovasc Pharmacother"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00259-w","article-title":"Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis","volume":"19","author":"Dalia","year":"2021","journal-title":"Thromb J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0036","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamacardio.2020.0652","article-title":"Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi","volume":"5","author":"Robinson","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0037","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jacc.2022.01.011","article-title":"Left ventricular thrombus following acute myocardial infarction: JACC state-of-the-art review","volume":"79","author":"Camaj","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0038","doi-asserted-by":"crossref","first-page":"40107","DOI":"10.1021\/acsami.7b14281","article-title":"A positively charged surface triggers coagulation activation through factor VII activating protease (FSAP)","volume":"9","author":"Sperling","year":"2017","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0039","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.ATV.0000229658.76797.30","article-title":"Flow effects on coagulation and thrombosis","volume":"26","author":"Hathcock","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MAT.0000000000001230","article-title":"Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: a systematic review","volume":"67","author":"Olson","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0041","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ejcts\/ezz098","article-title":"2019 EACTS expert consensus on long-term mechanical circulatory support","volume":"56","author":"Potapov","year":"2019","journal-title":"Eur J Cardio-Thorac Surg"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0042","article-title":"Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial","volume":"10","author":"Andreas","year":"2017","journal-title":"Circ Hear Fail"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0043","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1161\/CIR.0000000000000507","article-title":"Recommendations for the use of mechanical circulatory support: ambulatory and community patient care: a scientific statement from the American Heart Association","volume":"135","author":"Cook","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/atm-20-4849","article-title":"Antiplatelet and anticoagulation strategies for left ventricular assist devices","volume":"9","author":"Loyaga-Rendon","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.31486\/toj.19.0022","article-title":"Cardiac transplantation: update on a road less traveled","volume":"19","author":"Gupta","year":"2019","journal-title":"Ochsner J"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0046","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/17512433.2019.1637733","article-title":"Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy","volume":"12","author":"Lam","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0047","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.healun.2020.01.1344","article-title":"Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy","volume":"39","author":"Bjerre","year":"2020","journal-title":"J Hear Lung Transplant"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0048","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac allograft vasculopathy: recent developments","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0049","doi-asserted-by":"crossref","first-page":"e14125","DOI":"10.1111\/ctr.14125","article-title":"The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: a systematic review and meta-analysis","volume":"35","author":"Aleksova","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cardfail.2022.12.012_bib0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.healun.2019.12.007","article-title":"Use of direct oral anticoagulants after heart transplantation","volume":"39","author":"Henricksen","year":"2020","journal-title":"J Hear Lung Transplant"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:56Z","timestamp":1761029396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1071916423000015"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.12.012","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}